We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Mouse Model Promotes Study of Heart Failure Genes

By Biotechdaily staff writers
Posted on 27 Nov 2003
Heart disease researchers have used a mouse model to identify groups of genes that influence the severity of heart failure and the likelihood of recovery.

Investigators at Duke University Medical Center (Durham, NC, USA) mated males of a mouse strain with mutations that conferred a very reproducible and severe form of heart failure with females from a healthy mouse strain. More...
By screening the genomes of the offspring, some of which suffered heart failure while others did not, the investigators identified genetic regions that modified the severity of heart failure.

Their paper, published in the December 1, 2003, issue of Human Molecular Genetics, described two regions, one on chromosome 13 and another on chromosome 18, that were linked to heart function and survival with heart failure. An additional region on chromosome 2 affected cardiac function with no effect on survival, while another on chromosome 4 influenced survival without impacting heart function in mice with heart failure.

"Our goal is to find novel genes that modify human heart failure by letting the mouse point us in the right direction,” explained senior author Dr. Howard Rockman, a cardiologist at Duke University Medical Center. "Such genes would provide us the means to identify those heart failure patients having subtle genetic differences that make them more susceptible to poor outcomes. That some genes affect cardiac function without affecting survival and vice versa suggests that distinct genes may underlie the gradual decline in heart function characteristic of heart failure and the risk of sudden death associated with the disease.”


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Clinical Informatics Platform
CLARION™
New
Chromogenic Culture System
InTray™ COLOREX™ ECC
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.